Categories: All postsCannabis

Planet 13 is experiencing unheard of growth, says Beacon Securities

Traffic numbers are in for the month of May for Nevada cannabis operation Planet 13 (Planet 13 Stock Quote, Chart CSE:PLTH) and they’re nothing short of outstanding, says Doug Cooper, analyst for Beacon Securities, who in a Wednesday report to clients reiterated his “Buy” recommendation and 12-month target of C$7.25, representing a projected return of 172 per cent at the time of publication.

Planet 13 said its pot SuperStore averaged 2,095 daily paying customers in May, up seven per cent from April and up 50 per cent from its November opening. The average ticket price was $90.63, up 1.1 per cent from April and up 14 per cent from November.

Cooper says that the combined traffic and ticket growth of eight per cent is “unheard of in the retail market.” Further, the analyst points out that in the state of Nevada, P13 has been growing its market share from 6.4 per cent in November to 9.2 per cent in March (and up to 12 per cent in Las Vegas’ Clark County). Cooper says that he can think of “no other company that has such a dominant market share within a rec-legal state.”

The company plans to open a cafe and bistro, which Cooper expects should help convert some of its daily customers (about 3,500 in May) who are not purchasing into buyers.

“P13 has clearly established itself as THE company in Nevada. It is a very attractive state and one in which multi-state operators need to establish themselves. P13 is incredibly undervalued not only on its own merits but also as its key strategic position. Wholesale revenue and lounge remain upsides to our model,” Cooper says.

Cooper is calling for fiscal 2019 revenue and Adjusted EBITDA of $82.1 million and $20.5 million, respectively, and fiscal 2020 revenue and Adjusted EBITDA of $109.5 million and $38.0 million, respectively.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: plth
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Should you buy AMZN? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Amazon (Amazon Stock… [Read More]

6 hours ago

These cannabis stocks will benefit most from reclassification

It happened. The move that everyone in the cannabis sector was hoping for came about swiftly on the last day… [Read More]

13 hours ago

Is AMD stock a buy? (May, 2024)

Following the company's first quarter results, Roth MKM analyst Suji Desilva has maintained his "Buy" rating on Advanced Micro Devices… [Read More]

13 hours ago

Is Wolfspeed stock still a buy?

Ahead of the company's third quarter results, Roth MKM analyst Scott Irwin has maintained his "Buy" rating on Wolfspeed (Wolfspeed… [Read More]

14 hours ago

WELL Health inks five-year deal with Microsoft

It's become one of the biggest players in the Canadian healthcare space, now WELL Health (WELL Health Stock Quote, Chart,… [Read More]

1 day ago

Is Thomson Reuters stock a buy right now?

Its stock has made a since last October, but is there more upside left in Thomson Reuters (Thomson Reuters Stock… [Read More]

2 days ago